Webinar Unite 4 CSE 7 Feb poster (3)

On behalf of YouAct and CHOICE for Youth & Sexuality we are delighted to invite you to the Unite4CSE Webinar on Thursday 1st February 6pm – 7pm (CET).

This webinar will provide an opportunity to find out more about our recent collaboration. Unite4CSE an exciting project funded by ShareNet which brought CSE advocates from Cyprus, Georgia, Poland, Romania and the Netherlands together to advance Comprehensive Sexuality Education in Europe.

The Webinar will be held through the BlueJeans platform, please follow the instruction below to join:

https://bluejeans.com/432049375

To join via Room System:

Video Conferencing System: bjn.vc -or-199.48.152.152

Meeting ID : 432049375

To join via phone:

1)  Dial:

+1.408.740.7256 (United States)

+1.888.240.2560 (US Toll Free)

(see all numbers – http://bluejeans.com/numbers)

2)  Enter Conference ID : 432049375

More about this project

Youth advocates from Cyprus, Georgia, Poland, Romania and the Netherlands joined forces for the “Europe Unite for CSE Rights” campaign, aimed at bringing attention to the need for comprehensive sexuality education (CSE) and for young people’s sexual and reproductive health and rights (SRHR) in each national context.

In November 2017, advocates met in Amsterdam to set-up concrete plans at national level, including meetings with volunteers, round tables and online campaigns. A core element of the project was the development and online dissemination of info-graphics on various topics relevant at national level. While Cyprus, Poland and Romania focused on promoting comprehensive sexuality education as a mean to prevent gender-based violence, in Georgia the focus was on encouraging the government to support raising awareness on SRHR among young people through their policies and programs. Netherlands, on the other hand, brought the attention to the need of a safer and more pleasant environment for lesbian, homosexual and bisexual students.

The info-graphics in English and national languages can be found here.

Comments are closed.